1. Home
  2. XMTR vs VCEL Comparison

XMTR vs VCEL Comparison

Compare XMTR & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Xometry Inc.

XMTR

Xometry Inc.

HOLD

Current Price

$39.96

Market Cap

2.1B

Sector

Technology

ML Signal

HOLD

Logo Vericel Corporation

VCEL

Vericel Corporation

HOLD

Current Price

$33.58

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
XMTR
VCEL
Founded
2013
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
1.7B
IPO Year
2021
1996

Fundamental Metrics

Financial Performance
Metric
XMTR
VCEL
Price
$39.96
$33.58
Analyst Decision
Buy
Strong Buy
Analyst Count
10
5
Target Price
$58.60
$58.50
AVG Volume (30 Days)
814.2K
742.6K
Earning Date
05-05-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
26.95
60.00
EPS
N/A
0.32
Revenue
$686,631,000.00
$276,259,000.00
Revenue This Year
$23.76
$19.10
Revenue Next Year
$18.38
$17.95
P/E Ratio
N/A
$104.91
Revenue Growth
25.87
16.45
52 Week Low
$20.95
$28.95
52 Week High
$73.87
$45.97

Technical Indicators

Market Signals
Indicator
XMTR
VCEL
Relative Strength Index (RSI) 43.26 51.53
Support Level $39.50 $31.24
Resistance Level $42.98 $34.77
Average True Range (ATR) 2.59 1.66
MACD 0.67 0.39
Stochastic Oscillator 30.94 74.14

Price Performance

Historical Comparison
XMTR
VCEL

About XMTR Xometry Inc.

Xometry Inc is engaged in providing AI-enabled manufacturing equipment. Its buyers include engineers, product designers, procurement and supply chain personnel, inventors, and business owners. The manufacturing processes offered by the company include CNC Machining, Injection Molding, Urethane Casting, 3D Printing, and Die Casting. The company is organized into two segments referred to as the U.S. and the International. The majority of its revenue is derived from the U.S. segment.

About VCEL Vericel Corporation

Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Share on Social Networks: